People: Vioquest Pharmaceuticals Inc (VOQP.PK)

VOQP.PK on OTC Markets Group

0.01USD
19 Sep 2014
Price Change (% chg)

$-0.00 (-30.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
200
Avg. Vol
169
52-wk High
$0.02
52-wk Low
$0.01

Search Stocks

Summary

Name Age Since Current Position

Christopher Schnittker

44 2008 Chief Financial Officer, Vice President

Vernon Alvarez

2008 Vice President - Research & Development

Johnson Lau

51 2005 Director

Wayne Mills

51 2010 Director

Biographies

Name Description

Christopher Schnittker

Christopher P. Schnittker is Vice President and Chief Financial Officer since July 2008. He served as the Senior Vice President and Chief Financial Officer for Micromet, Inc., from October 2006 to December 2007. Mr. Schnittker also served as Senior Vice President and Chief Financial Officer for Cytogen Corporation, a publicly-traded biopharmaceutical company, from September 2003 to June 2006. From June 2000 to August 2003, Mr. Schnittker was Senior Vice President, Chief Financial Officer, and Corporate Secretary of Genaera Corporation (formerly Magainin Pharmaceuticals, Inc.). Mr. Schnittker received his B.A. degree in Economic and Business, with a concentration in Accounting, from Lafayette College. Mr. Schnittker is a certified public accountant licensed in the State of New Jersey.

Vernon Alvarez

Vernon Alvarez has served as a consultant to the Company since February 2008. Prior to that, Dr. Alvarez was a consultant from July 2007 to February 2008 for Cytogen Corp. From March 2001 to June 2006, Dr. Alvarez was the Vice President of Research and Development for TransMolecular, Inc.

Johnson Lau

Johnson Y.N. Lau, M.B.B.S., M.D., F.R.C.P., has been a member of board of directors since November 2005. He currently serves as the Chairman of Kinex Pharmaceuticals, LLC, a position he has held since December 2003. Dr. Lau currently is a member of the board of directors of Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP), a publicly-held company. Prior to his position with Kinex Pharmaceuticals, Dr. Lau was an independent contractor from January 2003 until December 2003 and served in various capacities at Ribapharm Inc. from August 2000 until January 2003, including Chairman, President and Chief Executive Officer. Previously he was the Senior Vice President and Head of Research and Development at ICN Pharmaceuticals and Senior Director of Antiviral Therapy at Schering-Plough Research Institute. He has published over 200 scientific papers and 40 reviews and editorials in leading academic journals and was elected as a Fellow, Royal College of Physicians in 2004. Dr. Lau holds an M.B.B.S. and M.D. from the University of Hong Kong and the degrees of M.R.C.P. and F.R.C.P. from the Royal College of Physicians.

Wayne Mills

Basic Compensation

Name Fiscal Year Total

Christopher Schnittker

--

Vernon Alvarez

--

Johnson Lau

--

Wayne Mills

--
As Of 

Options Compensation

Search Stocks